W
Weiwei Gao
Researcher at University of California, San Diego
Publications - 252
Citations - 21786
Weiwei Gao is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Graphene & Medicine. The author has an hindex of 69, co-authored 205 publications receiving 14280 citations. Previous affiliations of Weiwei Gao include Harvard University & University of California.
Papers
More filters
Journal ArticleDOI
A facile in situ method to fabricate transparent, flexible polyvinyl alcohol/ZnO film for UV-shielding
TL;DR: In this article, a homogeneous polyvinyl alcohol (PVA)/zinc oxide (ZnO) film was fabricated via a facile in situ method by controlling the reaction of Zn2+ with OH- ions and the dehydration process of zn(OH)42- throughout PVA hydrogel matrix.
Journal ArticleDOI
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition.
Xiangzhao Ai,Dan Wang,Anna N. Honko,Yaou Duan,Igor Gavrish,Ronnie H. Fang,Anthony Griffiths,Weiwei Gao,Liangfang Zhang +8 more
TL;DR: In this article, the authors showed that increasing surface heparin density on the cellular nanosponges can promote their inhibition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Journal ArticleDOI
ACE2 Receptor-Modified Algae-Based Microrobot for Removal of SARS-CoV-2 in Wastewater.
Fangyu Zhang,Zhengxing Li,Lu Yin,Qiangzhe Zhang,Nelly Askarinam,Rodolfo Mundaca-Uribe,Farshad Tehrani,Emil Karshalev,Weiwei Gao,Liangfang Zhang,Joseph Wang +10 more
TL;DR: In this article, an active biohybrid microrobot system that offers highly efficient capture and removal of target virus from various aquatic media is presented, which is fabricated by using click chemistry to functionalize microalgae with angiotensin-converting enzyme 2 (ACE2) receptor against the SARS-CoV-2 spike protein.
Journal ArticleDOI
Physical Disruption of Solid Tumors by Immunostimulatory Microrobots Enhances Antitumor Immunity.
Jiarong Zhou,Emil Karshalev,Rodolfo Mundaca-Uribe,Berta Esteban-Fernández de Ávila,Nishta Krishnan,Crystal Xiao,Christian J Ventura,Hua Gong,Qiangzhe Zhang,Weiwei Gao,Ronnie H. Fang,Joseph Wang,Liangfang Zhang +12 more
TL;DR: In this article, a microrobot-based strategy that integrates tumor tissue disruption with biological stimulation is shown for cancer immunotherapy, which can improve clinical outcomes through unique synergisms.